Pharmalex and Vintura have the pleasure to invite you to a discussion dedicated to healthcare system resilience during and after the pandemic from the perspective of Patient Access to innovation and optimal care.
The COVID-19 pandemic has had a dramatic and, in some cases, fundamental impact on our healthcare systems and our society at large. It has accelerated some phenomena, both positive and negative, slowed, or stopped others, and precipitated an entirely new set of processes, approaches, and perceptions. Above all, however, this time of crisis has revealed deep issues with the resilience of our healthcare systems across all of their dimensions from formal patient access (approval and availability of treatments and procedures) to therapeutic patient access (optimal care provision in the best setting). We have also been challenged, at a country and European level, in the way we assess and implement the Three Pillars of the good healthcare system: Solidarity, Sustainability, and Quality. It is against this background that our three eminent experts, representing different perspectives (Policy, Health Economics, and Clinical) will debate how will the health ecosystems look in the next few years - retaining some of the COVID-induced elements, rejecting others, and evolving across the board.
Cardiologist and Chief Knowledge Officer, Madrid
Doctor Maria Luaces is a specialist in Cardiology at the Hospital Clínico San Carlos in Madrid and associate Professor in the Department of Physiology at the University Complutense de Madrid.
She works in the Cardiac Imaging Section of the Cardiology Service of the Hospital Clínico San Carlos and is involved with Scientific and Strategic Management projects in the Innovation Unit of the Hospital Clínico San Carlos.
Since 2011, she collaborates with the Massachusetts Institute of Technology (MIT) and is actively working in the field of biomedical innovation training programs, leading the clinical curriculum.
Currently, this collaboration is carried out under the context of the European Innovation Office- EIT Health.
Warsaw University of Technology
Former Vice-Minister of Health, Poland
Prof. dr Marcin Czech is a professor and a head of the Department of Pharmacoeconomics at the Institute of Mother and Child in Warsaw, as well as postgraduate course director at Business School, Warsaw University of Technology. Czech is a highly respected HTA and Epidemiology expert and an advisor to health authorities worldwide, especially in lower income countries (Central and Eastern Europe, Central Asia and North Africa).
Czech is the President-elect of ISPOR, Poland Chapter and member of the Board of Directors at the Society of Co-ordinated Care.
Vice-minister in the Ministry of Health in Poland in the period of 07.2017-01.2019.
Professor of Health Economics, University of Ferrara
Prof. Fabrizio Ginafrate is a professor of Healthcare and Pharmaceutical Economics, Management and Legislation at LUISS (University and Business School of Association of Italian Manufacturers – Confindustria) in Rome and Public University of Ferrara.
Gianfrate is recognized for his expertise in the field of reimbursement, policy, innovative risk sharing agreements and coordinated care, and is a sought-after advisor to policy makers and the industry alike.
Registered journalist, columnist for healthcare and pharmaceuticals newspapers and magazines, Gianfrate is the Editor-in-Chief of Tecnica Ospedaliera and NCF.
Formerly a Director at Ministry of Health and General Manager and Vice President of Smith Kline Foundation Italy.